Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Revenue

Arovella Therapeutics had revenue of 3.21M AUD in the half year ending December 31, 2025, with 65.10% growth. This brings the company's revenue in the last twelve months to 3.21M, down -6.90% year-over-year. In the fiscal year ending June 30, 2025, Arovella Therapeutics had annual revenue of 3.44M with 76.22% growth.

• Revenue (ttm): 3.21M
• Revenue Growth: -6.90%
• P/S Ratio: 28.40
• Revenue / Employee: 118.88K
• Employees: 27
• Market Cap: 91.14M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.44M	1.49M	76.22%
Jun 30, 2024	1.95M	497.46K	34.20%
Jun 30, 2023	1.45M	1.16M	391.76%
Jun 30, 2022	295.81K	-693.91K	-70.11%
Jun 30, 2021	989.72K	-261.71K	-20.91%